Bayer Reports Unexpected Fourth-Quarter Loss on Schering Brand Writedown

Bayer AG posted its first quarterly loss in seven years on a writedown of the Schering drug brand and said pharmaceutical sales growth isn’t likely to match the market this year.
Bloomberg